Study of blood disorders in children with MDS or JMML
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at two childhood blood disorders—myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML). The goal is to describe how these conditions work in children and better understand them over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (as a caregiver) can give consent, and the child can agree too if possible
- A doctor has confirmed the diagnosis of MDS or JMML with lab tests
- If the condition is myeloid leukemia linked to Down syndrome, the child must be older than 6 years
- The child must be under 18 years old
- The child should not be enrolled in another study within the last 4 weeks (with limited exceptions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
This study looks at special stem cells in the blood or bone marrow of people with myelodysplastic syndromes (MDS). It aims to better predict how the disease might progress and help guide treatment decisions.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
This study collects and stores blood and bone marrow samples from young people with certain blood cancers so doctors can do genetic (“genomic”) testing now and in the future. It may help improve understanding of the disease and support better matching of care for patients.
Hear when a new Myelodysplastic Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.